Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Entinostat

EU orphan designation number: EU/3/10/732   
Active ingredient: Entinostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Southwood Research Limited
Gustav Mahlerplein 2, 1082MA Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan designation EMEA/OD/150/09 (2010)3901 of 10/06/2010
12/02/2013 Change of name and/or address of sponsor
28/04/2015 Transfer of orphan designation EMA/OD/150/09/T/01 (2015)2953 of 24/04/2015
25/02/2019 Transfer of orphan designation EMA/OD/0000004131 (2019)1631 of 21/02/2019